Abstract

Although protein kinase C (PKC) has been widely implicated in the positive and negative control of proliferation, the underlying cell cycle mechanisms regulated by individual PKC isozymes are only partially understood. In this report, we show that PKCdelta mediates phorbol ester-induced G1 arrest in lung adenocarcinoma cells and establish an essential role for this novel PKC in controlling the expression of the cell cycle inhibitor p21. Activation of PKC with phorbol 12-myristate 13-acetate (PMA) in early G1 phase impaired progression of lung adenocarcinoma cells into S phase, an effect that was completely abolished by specific depletion of PKCdelta, but not PKCalpha. Although the PKC effect was unrelated to the inhibition of cyclin D1 expression, PKC activation significantly up-regulated p21 and down-regulated Rb hyperphosphorylation and cyclin A expression. Elevations in p21 mRNA and protein by PMA were mediated by PKCdelta but not PKCalpha. Studies using luciferase reporters also revealed an essential role for PKCdelta in the PMA-induced inhibition of Rb-dependent cyclin A promoter activity. Finally, we showed that the cell cycle inhibitory effect of PKCdelta is greatly attenuated by RNA interference-mediated knock-down of p21. Our results identify a novel link between PKCdelta and G1 arrest via p21 up-regulation and highlight the complexities in the downstream effectors of PKC isozymes in the context of cell cycle progression and proliferation.

Highlights

  • Expression and function of different protein kinase C (PKC) isozymes and their downstream effectors in various types of human cancers, including lung, colon, prostate, and breast cancer, suggests that dysregulation of PKC signaling may be a factor in uncontrolled cell proliferation and neoplastic transformation [7,8,9,10,11,12]

  • phorbol 12-myristate 13-acetate (PMA) Induces G1 Arrest in Bronchoalveolar Cells via PKC Activation—To determine whether phorbol esters affect proliferation of lung adenocarcinoma cells, asynchronous H358 and H441 cells were treated with different concentrations of PMA (1 nM to 1 ␮M, 1 h)

  • Our studies have established that PKC␦, a member of the novel PKC family, mediates the anti-proliferative effect of PMA in lung adenocarcinoma cells

Read more

Summary

Introduction

Expression and function of different PKC isozymes and their downstream effectors in various types of human cancers, including lung, colon, prostate, and breast cancer, suggests that dysregulation of PKC signaling may be a factor in uncontrolled cell proliferation and neoplastic transformation [7,8,9,10,11,12]. By using RNAi to knock-down individual PKCs in a lung cancer cell model, we have determined an absolute requirement of PKC␦ for phorbol ester-induced G1 arrest. The Inhibitory Effect of PMA on G1/S Progression Is Mediated by PKC␦—H358 cells express three phorbol ester-responsive PKCs: one classic PKC (PKC␣) and two novel PKCs (PKC␦ and PKC⑀).

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call